Back to Trades
Betz Stephen F.
Chief Scientific OfficerCIK 0001886575
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, Betz Stephen F., Chief Scientific Officer, has disclosed $2.1M in transactions — all concentrated in Crinetics Pharmaceuticals, Inc. (CRNX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 25 | CRNX Crinetics Pharmaceuticals, Inc. | Betz Stephen F. | Chief Scientific Officer | Grant | $2.1M |
| Dec 29 | CRNX Crinetics Pharmaceuticals, Inc. | Betz Stephen F. | Chief Scientific Officer | Exercise | $68.8K |
2 filings